Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/D015415
http://purl.bioontology.org/ontology/MESH/D015415
|
|---|---|
| Preferred Name | Biomarkers |
| Definitions |
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
|
| Synonyms |
Biochemical Marker
Biological Markers
Markers, Biochemical
Surrogate Endpoints
Immune Markers
Markers, Immune
Marker, Biochemical
Clinical Marker
Viral Marker
Endpoint, Surrogate
Endpoints, Surrogate
Marker, Surrogate
Marker, Serum
Surrogate End Points
Marker, Immunologic
Biologic Marker
Markers, Laboratory
Marker, Laboratory
Biochemical Markers
Serum Markers
Markers, Biologic
Markers, Viral
Immune Marker
Serum Marker
Marker, Biological
Biological Marker
Immunologic Markers
Markers, Biological
Immunologic Marker
Surrogate End Point
End Points, Surrogate
Viral Markers
Marker, Immune
Biomarker
End Point, Surrogate
Marker, Viral
Marker, Biologic
Markers, Immunologic
Clinical Markers
Biologic Markers
Marker, Clinical
Laboratory Markers
Surrogate Marker
Markers, Surrogate
Surrogate Endpoint
Laboratory Marker
Markers, Serum
Surrogate Markers
Markers, Clinical
See more
See less
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. |
|---|---|
| altLabel |
Biochemical Marker
Biological Markers
Markers, Biochemical
Surrogate Endpoints
Immune Markers
Markers, Immune
Marker, Biochemical
Clinical Marker
Viral Marker
Endpoint, Surrogate
Endpoints, Surrogate
Marker, Surrogate
Marker, Serum
Surrogate End Points
Marker, Immunologic
Biologic Marker
Markers, Laboratory
Marker, Laboratory
Biochemical Markers
Serum Markers
Markers, Biologic
Markers, Viral
Immune Marker
Serum Marker
Marker, Biological
Biological Marker
Immunologic Markers
Markers, Biological
Immunologic Marker
Surrogate End Point
End Points, Surrogate
Viral Markers
Marker, Immune
Biomarker
End Point, Surrogate
Marker, Viral
Marker, Biologic
Markers, Immunologic
Clinical Markers
Biologic Markers
Marker, Clinical
Laboratory Markers
Surrogate Marker
Markers, Surrogate
Surrogate Endpoint
Laboratory Marker
Markers, Serum
Surrogate Markers
Markers, Clinical
See more
See less
|
| prefLabel | Biomarkers
|
| Machine permutation | 2016; See BIOLOGICAL MARKERS 1989-2015
|
| HN | 2016(1989)
|
| Mapped from |
See more
See less
|
| type | |
| tui |
T201
T080
|
| TERMUI |
T045514
T045505
T045485
T045490
T045499
T045511
T045500
T045503
T045487
T045502
T045488
T045513
T045482
T045498
T045497
T045510
T045481
T045508
T045486
T045501
T045509
T045492
T045504
T045491
T045489
T045493
T045495
T045507
T000995957
T045506
T045478
T045477
T045512
T045483
T686148
T045496
T045479
T045484
T045480
T045494
See more
See less
|
| TH |
NLM (1997)
NLM (1993)
NLM (2008)
NLM (1990)
NLM (1994)
NLM (1992)
UNK (19XX)
NLM (2021)
NLM (1989)
See more
See less
|
| MMR | 20200514
|
| notation | D015415
|
| Inverse of RO | |
| Semantic type UMLS property | |
| Inverse of AQ |
See more
See less
|
| FX |
D015335
D058068
|
| DX | 19890101
|
| cui |
C0162490
C0206015
C0162488
C0162489
C0162492
C0086589
C0005516
C0162491
C0008963
See more
See less
|
| DC | 1
|
| MN | D23.101
|
| AN | IM general only; coordinate with specific substance; note that many specific markers are available
|
| AQL | AN BL CF CH ME UR
|
| Inverse of RB | 0
|
| MDA | 20061116
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |